Cdt Equity Inc. (CDTTW) — SEC Filings
Cdt Equity Inc. (CDTTW) — 50 SEC filings. Latest: 8-K (Dec 12, 2025). Includes 29 8-K, 5 SC 13G/A, 4 10-Q.
View Cdt Equity Inc. on SEC EDGAR
Overview
Cdt Equity Inc. (CDTTW) is a publicly traded company tracked on ReadTheFiling. The most recent enriched filing is a 8-K filed on Dec 12, 2025: CDT Equity Inc. filed an 8-K on December 12, 2025, reporting on events that occurred on December 8, 2025. The filing indicates an entry into a material definitive agreement, unregistered sales of equity securities, and includes financial statements and exhibits. The company, formerly known as Condui
Sentiment Summary
Across 50 filings, the sentiment breakdown is: 6 bearish, 43 neutral, 1 mixed. The dominant filing sentiment for Cdt Equity Inc. is neutral.
Filing Type Overview
Cdt Equity Inc. (CDTTW) has filed 29 8-K, 4 10-Q, 1 10-Q/A, 3 DEF 14A, 2 8-K/A, 2 10-K, 5 SC 13G/A, 1 SC 13G, 1 SC 13D/A, 1 S-1/A, 1 S-1 with the SEC between Feb 2024 to Dec 2025.
Filings by Year
Recent SEC Filings (50)
Risk Profile
Risk Assessment: Of CDTTW's 44 recent filings, 6 were flagged as high-risk, 25 as medium-risk, and 13 as low-risk. The overall risk profile suggests moderate risk with a balanced mix of positive and cautionary disclosures.
Financial Highlights
| Metric | Value |
|---|---|
| Revenue | N/A |
| Net Income | -$7.1M |
| EPS | N/A |
| Debt-to-Equity | N/A |
| Cash Position | $3.8M |
| Operating Margin | N/A |
| Total Assets | N/A |
| Total Debt | N/A |
Key Executives
- David Tapolczay
Industry Context
CDT Equity Inc. operates in a dynamic sector where innovation and capital are crucial for growth. Companies in this space often face intense competition and require significant investment in research and development. The ability to secure ongoing funding is paramount, especially for early-stage or growth-focused entities.
Top Tags
corporate-governance (9) · material-agreement (8) · equity-sale (6) · filing (5) · pharmaceuticals (5) · amendment (4) · 10-Q (4) · governance (4) · financial-obligation (4) · financials (3)
Key Numbers
| Metric | Value | Context |
|---|---|---|
| Net Loss (Q3 2025) | $7.1M | Increased from $6.5M in Q3 2024 |
| Net Loss (9M 2025) | $17.9M | Increased from $15.4M in 9M 2024 |
| Accumulated Deficit | $47.0M | As of September 30, 2025, indicating significant historical losses |
| Cash and Cash Equivalents | $3.8M | As of September 30, 2025, up from $0.6M at Dec 31, 2024 |
| Cash Used in Operating Activities (9M 2025) | $10.9M | Increased from $5.9M in 9M 2024, showing higher burn rate |
| Proceeds from ATM Program | $17.9M | Key source of financing for the nine months ended September 30, 2025 |
| Common Shares Outstanding | 1,276,574 | As of September 30, 2025, significantly up from 11,540 at Dec 31, 2024, indicating dilution |
| General & Administrative Expenses (9M 2025) | $11.3M | Increased from $8.7M in 9M 2024 |
| Research & Development Expenses (9M 2025) | $4.3M | Increased from $3.2M in 9M 2024 |
| Period End Date | 2025-03-31 | The financial information pertains to this date. |
| Quarter Start Date | 2025-01-01 | The financial information pertains to this period. |
| Previous Year End Date | 2024-12-31 | Comparative financial data may be presented. |
| Central Index Key | 0001896212 | Unique identifier for CDT Equity Inc. |
| Filing Date | 20250808 | Date the 8-K was submitted to the SEC |
| Number of directors to be elected | 5 | Each for a one-year term expiring at the next annual meeting |
Forward-Looking Statements
- {"claim":"Polar Asset Management Partners Inc. will maintain a significant, albeit passive, stake in Conduit Pharmaceuticals Inc. for the foreseeable future.","entity":"Polar Asset Management Partners Inc.","targetDate":"12/31/2024","confidence":"medium"}
Related Companies
Frequently Asked Questions
What are the latest SEC filings for Cdt Equity Inc. (CDTTW)?
Cdt Equity Inc. has 50 recent SEC filings from Feb 2024 to Dec 2025, including 29 8-K, 5 SC 13G/A, 4 10-Q. Each filing includes an AI-generated plain-English summary.
What is the overall sentiment of CDTTW filings?
Across 50 filings, the sentiment breakdown is: 6 bearish, 43 neutral, 1 mixed. The dominant sentiment is neutral.
Where can I find Cdt Equity Inc. SEC filings explained simply?
ReadTheFiling provides AI-powered plain-English summaries of all Cdt Equity Inc. (CDTTW) SEC filings, including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and insider trades.
What are the key financial highlights for Cdt Equity Inc.?
Key financial highlights from Cdt Equity Inc.'s most recent 10-Q include metrics such as revenue, net income, EPS, and debt ratios. Visit the filing detail page for the full breakdown.
What is the investment thesis for CDTTW?
The investment thesis for CDTTW includes bull, base, and bear case scenarios derived from AI analysis of recent SEC filings.
Who are the key executives at Cdt Equity Inc.?
Key executives identified across Cdt Equity Inc.'s filings include David Tapolczay.
What are the main risk factors for Cdt Equity Inc. stock?
Of CDTTW's 44 assessed filings, 6 were flagged high-risk, 25 medium-risk, and 13 low-risk.
What are recent predictions and forward guidance from Cdt Equity Inc.?
Recent forward-looking statements from Cdt Equity Inc. include guidance on {"claim":"Polar Asset Management Partners Inc. will maintain a significant, albeit passive, stake in Conduit Pharmaceuti.